Ruxoprubart Granted Orphan Drug Designation for Paroxysmal Nocturnal Hemoglobinuria (PNH)
JerzyGorecki / Pixabay

Ruxoprubart Granted Orphan Drug Designation for Paroxysmal Nocturnal Hemoglobinuria (PNH)

Developing novel therapeutics for rare diseases is increasingly important. Understanding the unmet needs of rare disease communities and providing effective, accessible therapies can significantly improve the lives of those affected.…

Continue Reading Ruxoprubart Granted Orphan Drug Designation for Paroxysmal Nocturnal Hemoglobinuria (PNH)
Florida State University Harnesses Interdisciplinary Collaboration Through New Institute for Pediatric Rare Diseases
source: pixabay.com

Florida State University Harnesses Interdisciplinary Collaboration Through New Institute for Pediatric Rare Diseases

When it comes to rare disease, rare isn't actually that rare. More than 10,000 rare diseases have been identified. Rare diseases affect more than 350 million people across the globe…

Continue Reading Florida State University Harnesses Interdisciplinary Collaboration Through New Institute for Pediatric Rare Diseases
Dupixent Label Expands to Include Children Ages 1-11 with Eosinophilic Esophagitis
source: pixabay.com

Dupixent Label Expands to Include Children Ages 1-11 with Eosinophilic Esophagitis

In late January 2024, the U.S. Food and Drug Administration approved a label expansion for Dupixent (dupilumab). Dupixent, a monoclonal antibody targeting IL-4 and IL-13, is currently used to treat…

Continue Reading Dupixent Label Expands to Include Children Ages 1-11 with Eosinophilic Esophagitis
Rare Community Profiles: Unraveling the Genetic Threads: Erin’s Quest to Test for ALSP
Fotocitizen / Pixabay

Rare Community Profiles: Unraveling the Genetic Threads: Erin’s Quest to Test for ALSP

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: Unraveling the Genetic Threads: Erin’s Quest to Test for ALSP
Four-Year-Old Boy Tackles Sturge-Weber Syndrome Through Presymptomatic Treatment
https://pixabay.com/en/boy-people-silhouette-bokeh-blur-1209000/

Four-Year-Old Boy Tackles Sturge-Weber Syndrome Through Presymptomatic Treatment

At four and a half years old, Tucker Lewis is thriving. He loves playing with his friends, riding his bike outside, and watching the Atlanta Braves (He's even going to…

Continue Reading Four-Year-Old Boy Tackles Sturge-Weber Syndrome Through Presymptomatic Treatment
Prilenia Therapeutics Announces Data Supporting Initiation of Phase III ALS Study
source: shutterstock.com

Prilenia Therapeutics Announces Data Supporting Initiation of Phase III ALS Study

Prilenia Therapeutics, Waltham, Massachusetts and Naarden, Netherlands is a biotechnology company with a focus on developing therapeutics to treat neurodevelopmental disorders and neurodegenerative diseases. Prilenia presented data this month at…

Continue Reading Prilenia Therapeutics Announces Data Supporting Initiation of Phase III ALS Study
Rare Black History: After A Childhood Home of Rare Disease Patient Henrietta Lacks Was Demolished, Statues Were Raised
source: pixabay.com

Rare Black History: After A Childhood Home of Rare Disease Patient Henrietta Lacks Was Demolished, Statues Were Raised

According to a story from the Baltimore Sun, a childhood home of Henrietta Lacks - a Black woman often dubbed "the mother of modern medicine" - was unknowingly demolished just…

Continue Reading Rare Black History: After A Childhood Home of Rare Disease Patient Henrietta Lacks Was Demolished, Statues Were Raised
STUDY: Palliative Telecare Conferred Quality-of-Life Improvements in COPD
Source: https://pixabay.com/en/upper-body-lung-copd-disease-944557/

STUDY: Palliative Telecare Conferred Quality-of-Life Improvements in COPD

Treatments and management plans exist for chronic obstructive pulmonary disease (COPD), heart failure, and interstitial lung disease (ILD). Yet despite these treatments, many people with these conditions still experience chronic…

Continue Reading STUDY: Palliative Telecare Conferred Quality-of-Life Improvements in COPD

Pre-Clinical Safety Data Available on DA-1241 Combination for Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Metabolic dysfunction-associated steatohepatitis (MASH) unfortunately has no treatments to reverse the disease or its damage. MASH can be managed through weight loss, regular exercise, and blood sugar management. But identifying…

Continue Reading Pre-Clinical Safety Data Available on DA-1241 Combination for Metabolic Dysfunction-Associated Steatohepatitis (MASH)
ASCO GI Symposium: Fostrox-Lenvima Combo Treatment Show Clinical Benefit in Treating HCC
source: shutterstock.com

ASCO GI Symposium: Fostrox-Lenvima Combo Treatment Show Clinical Benefit in Treating HCC

Despite novel treatment advances, hepatocellular carcinoma (HCC) remains difficult to treat. This aggressive cancer is often not found until later stages and not all people with HCC can utilize available…

Continue Reading ASCO GI Symposium: Fostrox-Lenvima Combo Treatment Show Clinical Benefit in Treating HCC
Encouraging Results in Advanced Gastroenteropancreatic Neuroendocrine Tumors Phase III Trials
source: shutterstock.com

Encouraging Results in Advanced Gastroenteropancreatic Neuroendocrine Tumors Phase III Trials

The primary outcome from the Phase III NETTER-2 clinical trial as reported recently in Globe Newswire, was heralded as extending progression free survival from 8.5 months to 22.8. The participants…

Continue Reading Encouraging Results in Advanced Gastroenteropancreatic Neuroendocrine Tumors Phase III Trials
Pioneering Genetic Testing Access Through Probably Genetic’s Whole Exome Sequencing for Alpha-Mannosidosis
source: shutterstock.com

Pioneering Genetic Testing Access Through Probably Genetic’s Whole Exome Sequencing for Alpha-Mannosidosis

Patient Worthy is excited to highlight Probably Genetic's free genetic testing program for alpha-mannosidosis. The intricate web of rare diseases often leaves individuals and their families searching for answers and…

Continue Reading Pioneering Genetic Testing Access Through Probably Genetic’s Whole Exome Sequencing for Alpha-Mannosidosis